Dexcom and Abbott Await Medicare CGM Coverage Expansion for Non-Insulin Diabetes Patients

Two of the biggest names in diabetes technology — Dexcom and Abbott — are closely monitoring an anticipated Medicare CGM coverage expansion that could open access to continuous glucose monitors for millions of Americans with Type 2 diabetes who do not use insulin. A Major Policy Shift on the Horizon Currently, Medicare coverage for continuous […]

The post Dexcom and Abbott Await Medicare CGM Coverage Expansion for Non-Insulin Diabetes Patients first appeared on HHM Global | B2B Online Platform & Magazine.